Rick Wise
Stock Analyst at Stifel
(4.08)
# 468
Out of 5,182 analysts
268
Total ratings
58.72%
Success rate
9.03%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $110 → $90 | $61.79 | +45.65% | 19 | Mar 20, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $98 | $73.18 | +33.92% | 4 | Feb 5, 2026 | |
| JNJ Johnson & Johnson | Maintains: Hold | $205 → $220 | $238.46 | -7.74% | 8 | Jan 22, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $105 → $110 | $77.87 | +41.26% | 29 | Jan 20, 2026 | |
| MDLN Medline | Initiates: Buy | $46 | $45.60 | +0.88% | 1 | Jan 12, 2026 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $5 → $3 | $1.81 | +65.75% | 10 | Jan 7, 2026 | |
| SOLV Solventum | Maintains: Buy | $88 → $105 | $65.79 | +59.60% | 2 | Jan 7, 2026 | |
| OM Outset Medical | Maintains: Buy | $14 → $8 | $4.20 | +90.48% | 6 | Jan 7, 2026 | |
| LIVN LivaNova | Maintains: Buy | $65 → $70 | $62.78 | +11.50% | 7 | Jan 7, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $210 → $215 | $154.22 | +39.41% | 9 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $26.95 | +48.42% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $15.97 | +25.23% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $105 | $87.21 | +20.40% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $46 | $37.63 | +22.24% | 8 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $118 | $93.12 | +26.72% | 16 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $36 → $25 | $17.15 | +45.77% | 9 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $5 | $1.37 | +264.96% | 5 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $55 | $36.74 | +49.70% | 12 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $100.30 | +44.57% | 21 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $17.87 | +56.69% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $28.23 | +70.03% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $339.15 | +29.74% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $450.62 | +35.37% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $178.32 | +6.55% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $5.95 | +101.68% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $114.62 | -34.57% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $19.18 | +25.13% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $14.18 | +76.30% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $63.13 | +77.41% | 5 | Oct 2, 2020 |
Boston Scientific
Mar 20, 2026
Maintains: Buy
Price Target: $110 → $90
Current: $61.79
Upside: +45.65%
GE HealthCare Technologies
Feb 5, 2026
Maintains: Buy
Price Target: $95 → $98
Current: $73.18
Upside: +33.92%
Johnson & Johnson
Jan 22, 2026
Maintains: Hold
Price Target: $205 → $220
Current: $238.46
Upside: -7.74%
Edwards Lifesciences
Jan 20, 2026
Maintains: Buy
Price Target: $105 → $110
Current: $77.87
Upside: +41.26%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $46
Current: $45.60
Upside: +0.88%
Treace Medical Concepts
Jan 7, 2026
Maintains: Hold
Price Target: $5 → $3
Current: $1.81
Upside: +65.75%
Solventum
Jan 7, 2026
Maintains: Buy
Price Target: $88 → $105
Current: $65.79
Upside: +59.60%
Outset Medical
Jan 7, 2026
Maintains: Buy
Price Target: $14 → $8
Current: $4.20
Upside: +90.48%
LivaNova
Jan 7, 2026
Maintains: Buy
Price Target: $65 → $70
Current: $62.78
Upside: +11.50%
Becton, Dickinson and Company
Jan 7, 2026
Maintains: Buy
Price Target: $210 → $215
Current: $154.22
Upside: +39.41%
Nov 13, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $26.95
Upside: +48.42%
Oct 10, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $15.97
Upside: +25.23%
Oct 9, 2025
Maintains: Hold
Price Target: $90 → $105
Current: $87.21
Upside: +20.40%
Sep 29, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $37.63
Upside: +22.24%
Sep 19, 2025
Maintains: Buy
Price Target: $115 → $118
Current: $93.12
Upside: +26.72%
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $17.15
Upside: +45.77%
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.37
Upside: +264.96%
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $36.74
Upside: +49.70%
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $100.30
Upside: +44.57%
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $17.87
Upside: +56.69%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $28.23
Upside: +70.03%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $339.15
Upside: +29.74%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $450.62
Upside: +35.37%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $178.32
Upside: +6.55%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $5.95
Upside: +101.68%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $114.62
Upside: -34.57%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $19.18
Upside: +25.13%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $14.18
Upside: +76.30%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $63.13
Upside: +77.41%